Further studies of its clinically relevant traits subsequently determined that a high PXDN expression is often accompanied by a higher stage in prostate cancer, and this could be one of the reasons associated with a poor prostate cancer prognosis. The gene discussed is PXDN; the disease is prostate carcinoma.